HNRNPCL1 and metastatic malignant neoplasm in the lymph nodes: Moreover, HC-SMGs such as MUC19, MAN2A1 and HNRNPCL1 were exclusively mutated in rNEN-L patients with lymph node metastases, suggesting their involvement in the increasingly aggressive behavior of this disease.